Iron overload is prevalent among adults with sickle cell disease (SCD), according to a study presented at the annual meeting ...

Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...

September 18, 2024 (Houston Style Magazine) — In a historic move aimed at spotlighting a vital public health issue, the U.S. Department of Health and Human Services (HHS) will hold its first-ever ...

Experts call for consistent, specialist care throughout life to prevent complications and improve outcomes for people with ...

Piper Sandler boosted its target price to $23 per share from $16. ・Wainwright increased its price target to $25 from $18, ...

Sickle cell disease (SCD) can affect people of any ethnicity but is much more common among Africans and African Americans. Other ethnic groups with higher rates of SCD include Hispanic Americans from ...

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

Research suggests sickle cell anemia may offer some protection against HIV and may also slow HIV progression. However, experts still need further research to understand why this occurs. Share on ...